APRI : Summary for Apricus Biosciences, Inc. - Yahoo Finance

U.S. Markets closed

Apricus Biosciences, Inc. (APRI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.20-0.04 (-3.23%)
At close: 4:00 PM EST
People also watch:
ANTHBIODCPRXALIMATOS
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.24
Open1.24
Bid1.03 x 200
Ask2.04 x 4900
Day's Range1.15 - 1.24
52 Week Range0.26 - 2.98
Volume104,552
Avg. Volume468,573
Market Cap9.28M
Beta-0.62
PE Ratio (TTM)-0.74
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire8 days ago

    Apricus Biosciences Receives Nasdaq Compliance Notice

    Company Intends to Request Hearing SAN DIEGO, Dec. 01, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, ...

  • GlobeNewswire8 days ago

    Apricus Biosciences Receives Nasdaq Compliance Notice

    SAN DIEGO, Dec. 01, 2016-- Apricus Biosciences, Inc., a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that on November 30, 2016, the Company received ...

  • GlobeNewswire10 days ago

    Apricus Biosciences to Present at the 9th Annual LD Micro Main Event

    SAN DIEGO, Nov. 29, 2016 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Richard ...